MedPath

Enhancing Consent for Alzheimer's Research

Not Applicable
Completed
Conditions
Alzheimer Disease
Interventions
Other: Routine Consent Procedure
Other: Enhanced Consent Procedure
Registration Number
NCT00453544
Lead Sponsor
University of California, San Diego
Brief Summary

The purpose of this study is to evaluate the efficacy of an enhanced consent procedure for patients with mild-to-moderate Alzheimer disease, and to identify factors and patient characteristics that predict the degree to which enhanced consent is more beneficial than routine consent procedures.

Detailed Description

Alzheimer disease can impair the capacity of patients to give informed consent for research participation. Studies of informed consent involving other patient populations suggest better understanding of consent-relevant information may be achieved through modifications in the consent delivery process, including incorporation of multimedia learning tools into the consent discussion.

In the present study, participants with Alzheimer disease and age-comparable healthy participants will be randomly assigned to review a hypothetical research protocol via routine or enhanced consent procedures. Participants will also complete standard cognitive and other rating scales so that we can characterize the sample, as well as evaluate the degree to which specific characteristics may be associated with need for enhanced consent procedures. Advances in the methods to optimize the informed consent process should enable future research participants to make more fully informed decisions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
252
Inclusion Criteria
  • Clinical diagnosis of mild to moderate possible or probable AD or demographically comparable healthy comparison subjects
  • Fluency in English
  • 50 yrs and older
  • Informed written consent (or written assent with consent from legally authorized representative)
Exclusion Criteria
  • Diagnosis of Lewy Body Dementia or Mild Cognitive Impairment
  • MMSE less than 15
  • Physical or medical conditions that preclude participants from completing tasks
  • Healthy comparison volunteers if they have a known neurologic or psychiatric condition that could impair neurocognitive functioning

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Routine consent - ARoutine Consent ProcedureThis was a comparison condition - a routine consent process, including a printed consent document, for a moderate risk hypothetical protocol
Enhanced consent - AEnhanced Consent ProcedureThe intervention was an enhanced consent process, including a multimedia aid for a moderate risk hypothetical protocol
Enhanced consent - BEnhanced Consent ProcedureThe intervention was an enhanced consent process, including multimedia aide for a higher risk hypothetical protocol
Routine consent - BRoutine Consent ProcedureThis was a comparison condition - a routine consent process, including a printed consent document, for a higher risk hypothetical protocol
Primary Outcome Measures
NameTimeMethod
AppreciationWithin session - immediately following administration of the MacCAT-CR Understanding subscale

MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) Appreciation subscale Minimum score = 0, Maximum Score = 6; Higher scores represent better understanding

Level of UnderstandingWithin session - administered approximately 2-3 minutes after completion of the simulated consent process.

Modified version of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) Understanding subscale.

Minimum value = 0, Maximum value = 26; higher scores represent better performance

ReasoningWithin session-immediately following administration of the MacCAT-CR Appreciation subscale

Reasoning subscale of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) Minimum score = 0; Maximum Score = 8; Higher scores mean better reasoning capacity

Expression of a ChoiceWithin session--immediately following administration of the MacCAT-CR Reasoning subscale

Expression of a Choice subscale of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR); Minimum score = 0, Maximum score = 2; higher scores represent more intact ability to express a clear choice

Secondary Outcome Measures
NameTimeMethod
Level of Satisfaction With Consent ProcessWithin session

Question - "The consent process was" rated from "Very easy" to "Very Hard"

1. Very Easy

2. Easy

3. No effect

4. Hard

5. Very hard Higher scores mean more difficult (less satisfaction) with the consent process

* with 1 being "Very Easy" and 5 being "Very hard"

Expressed Willingness to Participate in the Hypothetical ProtocolWithin session-last item of the Expression of a Choice Subscale, which itself was measured immediately after the MacCAT-CR Reasoning subscale

Question about willingness to consent in the protocol described 0 = No

1. = Yes

2. = Unsure

Trial Locations

Locations (1)

Veterans Affairs San Diego Healthcare System

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath